Pharmacokinetic Considerations for Controlledrelease Dosage Forms

Preview this chapter:

Pharmacokinetic Considerations for Controlledrelease Dosage Forms, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815274165/chapter-2-1.gif

The pharmaceutical industry has shown significant interest in controlledrelease dosage forms due to their ability to improve pharmacological therapy by providing prolonged and regulated drug administration. The pharmacokinetic properties of a medicine are essential in establishing its efficacy and safety in a therapeutic setting. Controlled-release dosage forms offer significant advantages, such as reduced dosing frequency, improved patient compliance, and fewer adverse effects. To maximize the use of these benefits, it is critical to understand the complex interplay between formulation design, pharmacological properties, and controlled release systems pharmacokinetics. This chapter examines the pharmacokinetic aspects of controlled-release formulations, providing insight into their drug-release methods, absorption, distribution, metabolism, and excretion. The chapter also delves into the various elements that influence the rate of drug release from controlled-release dosage forms. These aspects include mechanisms such as diffusion, dissolution, and erosion. This study also investigates the impact of these mechanisms on medication absorption in the gastrointestinal tract and their influence on the drug's pharmacokinetic characteristics. Furthermore, the chapter emphasizes the importance of employing modeling and simulation approaches to predict the behavior of pharmaceuticals released from controlled-release formulations. Furthermore, the chapter undertakes an endeavor to examine the impact of pharmacokinetic parameters on the dosing schedule, therapeutic monitoring, and methods to enhance bioavailability. The chapter also discusses the importance of tailored drug delivery methods for specific patients, as well as the potential of personalized medicine. Understanding the pharmacokinetic parameters of controlled-release formulations is critical for optimizing pharmaceutical treatment. Gained knowledge can guide the development of innovative drug delivery methods, enhance patient outcomes, and accelerate pharmaceutical sector advancements